MAPT and Alzheimer disease: Single Recognition Particle 14 (SRP14), a ribonucleoprotein complex targeting secretory proteins to the endoplasmic reticulum is upregulated in APOE2 carriers compared with non-carriers, highlighting its critical role in tau pathology and Aβ deposition in AD in vivo [22].